延长预防性抗生素用于初次及无菌性翻修全关节置换术:一项Meta分析
该Meta分析纳入18项研究共19153例初次及无菌性翻修全髋/全膝关节置换患者,比较术后抗生素预防≤24小时(标准治疗)与>24小时(延长预防)对假体周围感染的影响;延长预防组总体假体周围感染风险较标准治疗组低35%(P=.0004),初次全髋置换和无菌性翻修全膝/全关节置换中亦见降低,但初次全膝置换和无菌性翻修全髋置换无显著差异。
要点
- 延长预防组总体假体周围感染风险较标准治疗组低35%(P=.0004)。
- 初次全髋置换延长预防组假体周围感染风险低40%(P=.02),初次全膝置换无显著差异(P=.17)。
- 无菌性翻修全膝置换延长预防组假体周围感染风险低47%(P=.008),无菌性翻修全髋置换无显著差异(P=.36)。
核心结论
- 延长预防组较标准治疗组在全部全关节置换、初次全关节置换、初次全髋置换、无菌性翻修全关节置换及无菌性翻修全膝置换中假体周围感染风险更低。
- 初次全膝置换和无菌性翻修全髋置换中延长预防与标准治疗无显著差异。
研究设计与样本
- Meta分析,检索Cochrane系统评价数据库、Cochrane对照试验注册库、PubMed、MEDLINE、Web of Science、Ovid Embase、Elton B. Stephens CO及Cumulative Index to Nursing and Allied Health Literature,比较初次及无菌性翻修全髋/全膝关节置换患者接受术后抗生素预防≤24小时(标准治疗)与>24小时(延长预防)的结局。
- 共纳入18项研究、19153例患者;延长预防组包括口服和静脉抗生素方案;主要结局为假体周围感染;采用合并相对风险的随机效应Mantel-Haenszel模型比较队列。
主要发现
- 延长预防组较标准治疗组发生假体周围感染的可能性低35%(P=.0004)。
- 初次全关节置换中,延长预防组较标准治疗组发生假体周围感染的可能性低39%(P=.0008);初次全髋置换中低40%(P=.02);初次全膝置换无显著差异(P=.17)。
- 无菌性翻修全关节置换中,延长预防组较标准治疗组发生假体周围感染的可能性低36%(P=.007);无菌性翻修全膝置换中低47%(P=.008);无菌性翻修全髋置换未观察到获益(P=.36)。
关键数值与推荐
- 抗生素预防方案变异较大,第一代头孢菌素为两组最常用的抗生素。
- 延长预防组较标准治疗组总体假体周围感染风险低35%(P=.0004)。
- 初次全关节置换延长预防组较标准治疗组假体周围感染风险低39%(P=.0008);初次全髋置换低40%(P=.02);初次全膝置换无显著差异(P=.17)。
- 无菌性翻修全关节置换延长预防组较标准治疗组假体周围感染风险低36%(P=.007);无菌性翻修全膝置换低47%(P=.008);无菌性翻修全髋置换无显著差异(P=.36)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is growing interest in extended antibiotic prophylaxis (EAP) following total joint arthroplasty (TJA); however, the benefit of EAP remains controversial. For this investigation, both oral and intravenous antibiotic protocols were included in the EAP group. METHODS: The Cochrane Database of Systematic Reviews, Cochrane Register of Controlled Trials, PubMed, MEDLINE, Web of Science, Ovid Embase, Elton B. Stephens CO, and Cumulative Index to Nursing and Allied Health Literature were queried for literature comparing outcomes of primary and aseptic revision total hip arthroplasty (THA) and total knee arthroplasty (TKA) patients who were treated with either ≤24 hours of postoperative antibiotic prophylaxis (standard of care [SoC]) or >24 hours of EAP. The primary outcome was periprosthetic joint infection (PJI). A pooled relative-risk random-effects Mantel-Haenszel model was implemented to compare cohorts. RESULTS: There were 18 studies with a total of 19,153 patients included. There was considerable variation in antibiotic prophylaxis protocols with first-generation cephalosporins being the most commonly implemented antibiotic for both groups. Patients treated with EAP were 35% less likely to develop PJI relative to the SoC (P = .0004). When examining primary TJA, patients treated with EAP were 39% and 40% less likely to develop a PJI for TJA (P = .0008) and THA (P = .02), respectively. There was no significant difference for primary TKA (P = .17). When examining aseptic revision TJA, EAP led to a 36% and 47% reduction in the probability of a PJI for aseptic revision TJA (P = .007) and aseptic revision TKA (P = .008), respectively; there was no observed benefit for aseptic revision THA (P = .36). CONCLUSIONS: This meta-analysis demonstrated that patients treated with EAP were less likely to develop a PJI relative to those treated with the SoC for all TJA, primary TJA, primary THA, aseptic revision TJA, and aseptic revision TKA. There was no significant difference observed between EAP and SoC for primary TKA or aseptic revision THA.
引用
- Dasari SP, Kanumuri SD, Yang J, et al. Extended Prophylactic Antibiotics for Primary and Aseptic Revision Total Joint Arthroplasty: A Meta-Analysis. J Arthroplasty. 2024. PMID: 38237874. doi:10.1016/j.arth.2024.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。